Joint pain and musculoskeletal discomfort Musculoskeletal Diseases
Conditions
Interventions
This is a single-arm open-label clinical trial conducted among patients diagnosed with mild to moderate joint pain. Eligible participants will apply Ortho Shield Herbal Lotion twice daily (morning and
Sponsors
Fadna Life Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Adults aged 20–70 years, of either sex. 2. Diagnosed with mild to moderate arthritis or musculoskeletal pain for more than two weeks. 3. Willing to provide written informed consent. 4. Able to comply with the study protocol and follow-up schedule.
Exclusion criteria
Exclusion criteria: 1. Patients with serious systemic illnesses (e.g., rheumatoid arthritis, lupus, HIV). 2. Pregnant or breastfeeding women. 3. Patients currently using other pain-relieving topical or systemic medications. 4. Known hypersensitivity or allergy to any component of the lotion. 5. Presence of open wounds or infections at the application site.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Reduction in joint pain intensity measured using the McGill Pain Questionnaire at baseline and after two weeks of intervention. 2.Improvement in overall quality of life scores (QOL) assessed before and after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Assessment of skin sensitivity and local adverse reactions (e.g., redness, itching, swelling). 2. Change in blood pressure and heart rate before and after the intervention. 3. Participant-reported satisfaction and functional improvement scores. | — |
Countries
Sri Lanka
Contacts
Public ContactPathirage Kamal Perera
Outcome results
None listed